Key Highlights
- Teladoc Health (NYSE:TDOC) traded at USD 7.52, up 9.30%, in pre-market trading on Thursday, October 29, 2026, following the company's third quarter 2026 results released on Wednesday, October 28, 2026.
- For the quarter ended September 30, 2026, Revenue was USD 605.1 million, down 3%, while the net loss narrowed to USD 26.9 million, or USD 0.15 per share, from USD 49.5 million a year earlier.
- Adjusted EBITDA rose 14% to USD 79.4 million, free Cash Flow was USD 75.9 million and cash stood at USD 849.9 million, with full-year 2026 revenue guidance of USD 2,395 million to USD 2,441 million.
- BetterHelp revenue fell 13% and the pre-market price is a thinly traded snapshot, so the 9.30% advance can change before the open at 9:30 a.m. ET.
The Pre-Market Move and Its Catalyst
Teladoc Health (NYSE:TDOC), a provider of virtual healthcare and mental health services, traded at USD 7.52 in pre-market trading on Thursday, October 29, 2026, a gain of 9.30% in the pre-market snapshot. The catalyst is the company's release of Wednesday, October 28, 2026, which reported third quarter 2026 results. Consolidated revenue was USD 605.1 million, down 3% from USD 626.4 million a year earlier, yet the chief executive described the result as near the upper end of the guidance range for consolidated revenue. The net loss narrowed to USD 26.9 million from USD 49.5 million, and adjusted EBITDA, a non-GAAP measure of operating Earnings before certain costs, rose 14% to USD 79.4 million.
How the Latest Results Frame the Move
Teladoc Health (NYSE:TDOC) reported Integrated Care revenue of USD 398.5 million, up 2%, with an adjusted EBITDA Margin of 18.8%. BetterHelp revenue was USD 206.6 million, down 13%, with a margin of 2.2%. Insurance covered services at BetterHelp rose to USD 32.1 million from USD 3.7 million, while consumer and other revenue fell 25%. Free cash flow was USD 75.9 million and cash and cash equivalents were USD 849.9 million at September 30, 2026. Restructuring costs were USD 4.4 million. Guidance for the fourth quarter of 2026 is revenue of USD 569 million to USD 615 million and adjusted EBITDA of USD 74 million to USD 100 million. The advance appears consistent with a narrower loss and stronger cash generation outweighing lower revenue, which is an inference.
Risks and What to Watch
The bull reading rests on a narrower loss, a 14% rise in adjusted EBITDA, free cash flow of USD 75.9 million and early traction for the Teladoc One platform and the insurance covered business. The bear reading rests on falling consolidated revenue, a 13% decline at BetterHelp as out-of-pocket users decrease, and fourth quarter guidance for a net loss per share of USD 0.23 loss to USD 0.03 loss. Named risks include a wide guidance range, the pace of the shift to insurance billing and restructuring execution. Investors should watch the pre-market Liquidity into the open at 9:30 a.m. ET on Thursday, October 29, 2026, the fourth quarter results and updates on Teladoc One launches.
Where Things Stand
The answer is that Teladoc Health (NYSE:TDOC) appears to be rising because its third quarter results showed a narrower loss, higher adjusted EBITDA and substantial cash despite lower revenue. The key number is the USD 26.9 million net loss against USD 49.5 million a year earlier. The next catalysts are the open at 9:30 a.m. ET on Thursday, October 29, 2026, further Teladoc One launch updates and the fourth quarter results against guidance of USD 569 million to USD 615 million in revenue. Pre-market prices are snapshots and can change, and this is not Investment advice.






Please wait processing your request...